Gene Expression Profiles in Relation to Tension and Dissociation in Borderline Personality Disorder

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Schmahl, Christian ^a   Arvastson, Lars ^b   Tamm, Joseph A ^c   Bohus, Martin ^a   Abdourahman, Aicha ^c   Antonijevic, Irina ^c,d  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b H LUNDBECK A S   (Denmark)

^c LUNDBECK RESEARCH USA   (United States)

^d A Sanofi Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BETA ARRESTIN 1; BETA ARRESTIN 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 3; MOOD STABILIZER; SEROTONIN UPTAKE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE 1;

ADULT; ARTICLE; BLOOD ANALYSIS; BORDERLINE STATE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EMOTIONAL STRESS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOSPITAL PATIENT; HUMAN; IMMUNE SYSTEM; MENTAL DISSOCIATION; PILOT STUDY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ADULT; BORDERLINE PERSONALITY DISORDER; COMPUTATIONAL BIOLOGY; DEPRESSION; DISSOCIATIVE DISORDERS; FEMALE; HUMANS; PSYCHIATRIC STATUS RATING SCALES; TRANSCRIPTOME; YOUNG ADULT;

EID: 84881525917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070787     Document Type: Article

References (64)

1. Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ, (2010) Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord 24: 412-426.
2. Zanarini MC, (2000) Childhood experiences associated with the development of borderline personality disorder. Psychiatr Clin North Am 23: 89-101.
3. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, et al. (1998) Axis I comorbidity of borderline personality disorder. Am J Psychiatry 155: 1733-1739.
4. Zanarini MC, Ruser T, Frankenburg FR, Hennen J, (2000) The dissociative experiences of borderline patients. Compr Psychiatry 41: 223-227.
5. Stiglmayr CE, Shapiro DA, Stieglitz RD, Limberger MF, Bohus M, (2001) Experience of aversive tension and dissociation in female patients with borderline personality disorder - a controlled study. J Psychiatr Res 35: 111-118.
6. Stiglmayr CE, Ebner-Priemer UW, Bretz J, Behm R, Mohse M, et al. (2008) Dissociative symptoms are positively related to stress in borderline personality disorder. Acta psychiatrica Scandinavica 117: 139-147.
7. Ludascher P, Bohus M, Lieb K, Philipsen A, Jochims A, et al. (2007) Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry research 149: 291-296.
8. Brodsky BS, Cloitre M, Dulit RA, (1995) Relationship of dissociation to self-mutilation and childhood abuse in borderline personality disorder. Am J Psychiatry 152: 1788-1792.
9. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, et al. (2009) Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62: 479-493.
10. Gry M, Rimini R, Stromberg S, Asplund A, Ponten F, et al. (2009) Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 10: 365.
11. Gold PW, Chrousos GP, (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7: 254-275.
12. Gold PW, Gabry KE, Yasuda MR, Chrousos GP (2002) Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am 31: 37-62, vi.
13. Miller AH, Maletic V, Raison CL, (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732-741.
14. Howren MB, Lamkin DM, Suls J, (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171-186.
15. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, et al. (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446-457.
16. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR, (2008) Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 64: 484-490.
17. Schmahl CG, Vermetten E, Elzinga BM, Douglas Bremner J, (2003) Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res 122: 193-198.
18. Schmahl C, Berne K, Krause A, Kleindienst N, Valerius G, et al. (2009) Hippocampus and amygdala volumes in patients with borderline personality disorder with or without posttraumatic stress disorder. J Psychiatry Neurosci 34: 289-295.
19. Nunes PM, Wenzel A, Borges KT, Porto CR, Caminha RM, et al. (2009) Volumes of the hippocampus and amygdala in patients with borderline personality disorder: a meta-analysis. J Pers Disord 23: 333-345.
20. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, et al. (2009) Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66: 287-292.
21. Kahl KG, Bens S, Ziegler K, Rudolf S, Dibbelt L, et al. (2006) Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol Psychiatry 59: 667-671.
22. Westling S, Ahren B, Traskman-Bendz L, Brundin L, (2011) Increased IL-1beta reactivity upon a glucose challenge in patients with deliberate self-harm. Acta Psychiatr Scand 124: 301-306.
23. Munkholm K, Vinberg M, Berk M, Kessing LV, (2012) State-related alterations of gene expression in bipolar disorder: a systematic review. Bipolar Disord 14: 684-696.
24. Belzeaux R, Formisano-Treziny C, Loundou A, Boyer L, Gabert J, et al. (2010) Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. J Psychiatr Res 44: 1205-1213.
25. Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Treziny C, et al. (2012) Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry 2: e185.
26. Blendy JA, (2006) The role of CREB in depression and antidepressant treatment. Biol Psychiatry 59: 1144-1150.
27. Bohus M, Forstner U, Kiefer C, Gebicke-Harter P, Timmer J, et al. (1996) Increased sensitivity of the inositol-phospholipid system in neutrophils from patients with acute major depressive episodes. Psychiatry Res 65: 45-51.
28. Iga J, Ueno S, Yamauchi K, Numata S, Motoki I, et al. (2006) Gene expression and association analysis of LIM (PDLIM5) in major depression. Neurosci Lett 400: 203-207.
29. Vollmayr B, Sulger J, Gabriel P, Aldenhoff JB, (1995) Mitogen stimulated rise of intracellular calcium concentration in single T lymphocytes from patients with major depression is reduced. Prog Neuropsychopharmacol Biol Psychiatry 19: 1263-1273.
30. Martini C, Da Pozzo E, Carmassi C, Cuboni S, Trincavelli ML, et al. (2011) Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder. World J Biol Psychiatry.
31. Lewis TS, Shapiro PS, Ahn NG, (1998) Signal transduction through MAP kinase cascades. Adv Cancer Res 74: 49-139.
32. Dwivedi Y, Rizavi HS, Conley RR, Pandey GN, (2006) ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 11: 86-98.
33. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, et al. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77: 916-928.
34. Trollope AF, Gutierrez-Mecinas M, Mifsud KR, Collins A, Saunderson EA, et al. (2012) Stress, epigenetic control of gene expression and memory formation. Exp Neurol 233: 3-11.
35. Avissar S, Matuzany-Ruban A, Tzukert K, Schreiber G, (2004) Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. Am J Psychiatry 161: 2066-2072.
36. Heim C, Plotsky PM, Nemeroff CB, (2004) Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29: 641-648.
37. Gouin JP, Glaser R, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK, (2012) Childhood abuse and inflammatory responses to daily stressors. Ann Behav Med 44: 287-292.
38. Segman RH, Shefi N, Goltser-Dubner T, Friedman N, Kaminski N, et al. (2005) Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 10: 500-513, 425.
39. Perroud N, Salzmann A, Prada P, Nicastro R, Hoeppli ME, et al. (2013) Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry 3: e207.
40. Loranger AW (1999) International Personality Disorder Examination (IPDE): DSM-IV and ICD-10 modules. Odessa: Psychological Assessment Resources.
41. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured Clinical Interview for Axis I DSM-IV Disorders- Patient Edition (SCID-I/P). New York: American Psychiatric Press.
42. Sullivan PF, Fan C, Perou CM, (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B: 261-268.
43. Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, et al. (2012) Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry 2: e101.
44. Stiglmayr CE, Braakmann D, Haaf B, Stieglitz RD, Bohus M, (2003) [Development and characteristics of Dissociation-Tension-Scale acute (DSS-Akute)]. Psychother Psychosom Med Psychol 53: 287-294.
45. Bohus M, Limberger MF, Frank U, Chapman AL, Kuhler T, et al. (2007) Psychometric properties of the Borderline Symptom List (BSL). Psychopathology 40: 126-132.
46. Sullivan PF, Daly MJ, O'Donovan M, (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13: 537-551.
47. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, et al. (2009) Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 14: 156-174.
48. Ebner-Priemer UW, Badeck S, Beckmann C, Wagner A, Feige B, et al. (2005) Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study. J Psychiatr Res 39: 85-92.
49. Krause-Utz A, Oei NY, Niedtfeld I, Bohus M, Spinhoven P, et al. (2012) Influence of emotional distraction on working memory performance in borderline personality disorder. Psychol Med: 1-12.
50. Lanius RA, Vermetten E, Loewenstein RJ, Brand B, Schmahl C, et al. (2010) Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. Am J Psychiatry 167: 640-647.
51. Jang KL, Paris J, Zweig-Frank H, Livesley WJ, (1998) Twin study of dissociative experience. The Journal of nervous and mental disease 186: 345-351.
52. Becker-Blease KA, Deater-Deckard K, Eley T, Freyd JJ, Stevenson J, et al. (2004) A genetic analysis of individual differences in dissociative behaviors in childhood and adolescence. Journal of child psychology and psychiatry, and allied disciplines 45: 522-532.
53. Koenen KC, Saxe G, Purcell S, Smoller JW, Bartholomew D, et al. (2005) Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Molecular psychiatry 10: 1058-1059.
54. Savitz JB, van der Merwe L, Newman TK, Solms M, Stein DJ, et al. (2008) The relationship between childhood abuse and dissociation. Is it influenced by catechol-O-methyltransferase (COMT) activity? The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 11: 149-161.
55. Lochner C, Seedat S, Hemmings SM, Moolman-Smook JC, Kidd M, et al. (2007) Investigating the possible effects of trauma experiences and 5-HTT on the dissociative experiences of patients with OCD using path analysis and multiple regression. Neuropsychobiology 56: 6-13.
56. Lahmeyer HW, Val E, Gaviria FM, Prasad RB, Pandey GN, et al. (1988) EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Res 25: 19-30.
57. Korzekwa M, Steiner M, Links P, Eppel A, (1991) The dexamethasone suppression test in borderlines: is it useful? Can J Psychiatry 36: 26-28.
58. De la Fuente JM, Mendlewicz J, (1996) TRH stimulation and dexamethasone suppression in borderline personality disorder. Biol Psychiatry 40: 412-418.
59. Lieb K, Rexhausen JE, Kahl KG, Schweiger U, Philipsen A, et al. (2004) Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res 38: 559-565.
60. Nater UM, Bohus M, Abbruzzese E, Ditzen B, Gaab J, et al. (2010) Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder. Psychoneuroendocrinology 35: 1565-1572.
61. Black DW, Blum N, Pfohl B, Hale N, (2004) Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J Pers Disord 18: 226-239.
62. Higuchi F, Uchida S, Yamagata H, Otsuki K, Hobara T, et al. (2011) State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. J Psychiatr Res 45: 1295-1300.
63. Collins LJ, Penny D, (2009) The RNA infrastructure: dark matter of the eukaryotic cell? Trends Genet 25: 120-128.
64. Dammann G, Teschler S, Haag T, Altmuller F, Tuczek F, et al. (2011) Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder. Epigenetics 6: 1454-1462.